See more : Founders Bay Holdings (FDBH) Income Statement Analysis – Financial Results
Complete financial analysis of Galectin Therapeutics Inc. (GALT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Galectin Therapeutics Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Smart Agro – Limited (SMAG.TA) Income Statement Analysis – Financial Results
- Country Condo’s Limited (COUNCODOS.NS) Income Statement Analysis – Financial Results
- DocuSign, Inc. (0XNH.L) Income Statement Analysis – Financial Results
- PwrCor, Inc. (PWCO) Income Statement Analysis – Financial Results
- Kainos Group plc (KNOS.L) Income Statement Analysis – Financial Results
Galectin Therapeutics Inc. (GALT)
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 33.00K | 32.00K | 41.00K | 36.00K | 35.00K | 0.00 | 1.00K | 7.00K | 7.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.33M | 6.46M | 7.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -33.00K | -32.00K | -41.00K | -36.00K | -35.00K | 0.00 | -1.00K | -7.00K | -7.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -5.33M | -6.46M | -7.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 32.13M | 31.74M | 23.82M | 17.98M | 7.47M | 6.47M | 11.72M | 15.33M | 13.11M | 8.43M | 5.69M | 4.53M | 3.55M | 1.07M | 1.11M | 1.77M | 2.05M | 3.02M | 3.04M | 3.04M | 1.95M | 1.48M | 893.46K | 100.00K |
| General & Administrative | 5.90M | 6.62M | 6.36M | 5.47M | 5.97M | 7.13M | 4.53M | 6.16M | 6.97M | 7.01M | 6.42M | 5.37M | 6.86M | 3.82M | 4.98M | 3.55M | 4.40M | 4.03M | 3.62M | 4.26M | 2.99M | 1.80M | 1.29M | 70.00K |
| Selling & Marketing | 44.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.94M | 6.62M | 6.36M | 5.47M | 5.97M | 7.13M | 4.53M | 6.16M | 6.97M | 7.01M | 6.42M | 5.37M | 6.86M | 3.82M | 4.98M | 3.55M | 4.40M | 4.03M | 3.62M | 4.26M | 2.99M | 1.80M | 1.29M | 70.00K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 200.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 38.07M | 38.35M | 30.18M | 23.44M | 13.44M | 13.60M | 16.25M | 21.48M | 20.08M | 15.43M | 12.10M | 9.90M | 10.41M | 4.88M | 6.09M | 5.33M | 6.46M | 7.05M | 6.66M | 7.30M | 4.94M | 3.29M | 2.18M | 170.00K |
| Cost & Expenses | 38.07M | 38.35M | 30.18M | 23.44M | 13.44M | 13.60M | 16.25M | 21.48M | 20.08M | 15.43M | 12.10M | 9.90M | 10.41M | 4.88M | 6.09M | 5.33M | 6.46M | 7.05M | 6.66M | 7.30M | 4.94M | 3.29M | 2.18M | 170.00K |
| Interest Income | 0.00 | 52.00K | 3.00K | 66.00K | 231.00K | 38.00K | 24.00K | 45.00K | 52.00K | 42.00K | 16.00K | 24.00K | 18.00K | 6.00K | 3.00K | 30.00K | 102.00K | 281.00K | 111.00K | 124.00K | 68.93K | 24.26K | 24.92K | 0.00 |
| Interest Expense | 2.56M | 1.03M | 489.00K | 87.00K | 87.00K | 336.00K | 12.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 350.00K | 1.85M | 0.00 | 0.00 | 3.88K | 415.42K | 0.00 | 0.00 |
| Depreciation & Amortization | 38.07M | 32.00K | 41.00K | 36.00K | 35.00K | 1.00K | 1.00K | 7.00K | 7.00K | 10.00K | 12.00K | 9.00K | 9.00K | 12.00K | 37.00K | 49.00K | 64.00K | 67.00K | 81.00K | 81.00K | 89.17K | 211.18K | 159.47K | -20.00K |
| EBITDA | -202.00K | -37.71M | -30.00M | -23.34M | -13.17M | -13.56M | -16.23M | -21.47M | -20.07M | -15.78M | -12.08M | -9.67M | -10.91M | -5.62M | -7.43M | -3.10M | -9.02M | -1.28M | -6.77M | -7.10M | -4.85M | -3.08M | -2.02M | -190.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -38.07M | -38.35M | -30.18M | -23.44M | -13.44M | -13.60M | -16.25M | -21.48M | -20.08M | -15.43M | -12.10M | -9.90M | -10.41M | -4.88M | -6.09M | -5.33M | -6.46M | -7.05M | -6.66M | -7.30M | -4.94M | -3.29M | -2.18M | -170.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.99M | -424.00K | -348.00K | -21.00K | 144.00K | -298.00K | 12.00K | 45.00K | 52.00K | -358.00K | 16.00K | 224.00K | -506.00K | -746.00K | -1.37M | 2.18M | -2.98M | 3.86M | 111.00K | 124.00K | 65.05K | -391.16K | 0.00 | -20.00K |
| Income Before Tax | -41.07M | -38.78M | -30.53M | -23.47M | -13.29M | -13.90M | -16.24M | -21.44M | -20.03M | -15.79M | -12.09M | -9.68M | -10.92M | -5.63M | -7.46M | -3.15M | -9.43M | -3.19M | -6.54M | -7.18M | -4.87M | -3.68M | 0.00 | -190.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 424.00K | 448.00K | 51.00K | 87.00K | -123.14K | 24.00K | 0.00 | 0.00 | -52.00K | 16.00K | 200.00K | 506.00K | 746.00K | 1.37M | -2.18M | 2.98M | -3.86M | 0.00 | 0.00 | 0.00 | 0.00 | 1.79M | 0.00 |
| Net Income | -41.07M | -39.20M | -30.98M | -23.52M | -13.38M | -13.90M | -16.24M | -21.44M | -20.03M | -15.79M | -12.09M | -9.68M | -10.92M | -5.63M | -7.46M | -3.15M | -9.43M | -3.19M | -6.54M | -7.18M | -4.87M | -3.68M | -3.97M | -190.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 | -0.60 | -0.93 | -0.40 | -1.45 | -0.67 | -1.44 | -1.67 | -1.37 | -1.35 | -1.75 | -0.09 |
| EPS Diluted | -0.74 | -0.66 | -0.53 | -0.41 | -0.26 | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 | -0.72 | -0.64 | -0.91 | -0.60 | -0.93 | -0.40 | -1.45 | -0.67 | -1.44 | -1.67 | -1.37 | -1.35 | -1.75 | -0.09 |
| Weighted Avg Shares Out | 60.16M | 59.39M | 58.53M | 57.03M | 52.24M | 39.41M | 35.52M | 29.22M | 24.12M | 21.85M | 16.87M | 15.13M | 11.99M | 9.38M | 8.05M | 7.80M | 6.50M | 4.75M | 4.55M | 4.29M | 3.56M | 2.73M | 2.27M | 2.06M |
| Weighted Avg Shares Out (Dil) | 60.16M | 59.39M | 58.53M | 57.03M | 52.24M | 39.41M | 35.52M | 29.22M | 24.12M | 21.85M | 16.87M | 15.13M | 11.99M | 9.38M | 8.05M | 7.80M | 6.50M | 4.75M | 4.55M | 4.29M | 3.56M | 2.73M | 2.27M | 2.06M |
Cruise, GM to seek U.S. approval for vehicle with no pedal or steering wheel | Business
Self-driving car maker Cruise said on Wednesday it and majority shareholder General Motors Co would seek U.S. regulatory approval in coming months to deploy a limited number of Cruise Origin vehicles without steering wheels or pedals. At the same time,...
Nikola's Downward Slide Looks Set To Continue - The GM Deal Looks Shaky (NASDAQ:NKLA)
Nikola's prospects continue to weaken despite major changes at the company. The Nikola-GM deal appears shakier than ever.
GMC Hummer EV: 5 things to know about GM's first electric 'supertruck'
The 2022 Hummer EV is expected to be the pinnacle of General Motors' electric vehicles.
General Motors' New Electric Hummer Is a 1,000-Horsepower Tesla Fighter | The Motley Fool
GM designed the new Hummer EV to impress -- and priced it accordingly.
Nikola's stock surges after GM president said on CNBC he sees 'spectacular' opportunity in partnership
Shares of Nikola Corp. undefined surged 4.7% in morning trading Wednesday, after General Motors Corp. undefined President Mark Reuss said on CNBC that he saw...
GM unveils first electric Hummer ‘supertruck’ for $113,000
General Motors has resurrected its gas-guzzling Hummer SUV as an all-electric “supertruck” — souped up with high-tech features and a price to match. The Detroit automaker on Tuesday unv…
What to watch today: Stocks set for steady open after Tuesday's rally moderated
U.S. stock futures were little changed Wednesday morning as investors monitor coronavirus stimulus talks.
Even as It Struggles, DiamondPeak Stock Isn't Just All Story
The future of DiamondPeak stock will come down to whether the company can make the turnaround story at Lordstown complete.
Wall Street Breakfast: Can Tesla Hit 2020 Delivery Target?
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Source: https://incomestatements.info
Category: Stock Reports